A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

Hogan, Thomas P., Awad, A. G., Eastwood, Robin·1983·Psychological Medicine

Open this paper in CoChat — free account

Abstract

Synopsis: Schizophrenic patients' self-reports of their experience of neuroleptic treatment were used as the basis for the construction of a scale predictive of drug compliance. Reliability analysis of the responses of 150 patients indicated high internal consistency in the 30-item scale, and preliminary validation in the form of discriminant classification accurately assigned 89% of the sample to compliant and non-compliant groupings. Both discriminant and factor analyses suggest that maximum variability in responding is accounted for by items reflecting how the patient feels on medication, rather than what he knows or believes about medication.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1017/s0033291700050182

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No references could be resolved yet.

Research works printed but not linked: 32

10.1001/archpsyc.1978.01770330075006 · DOI · Paper page
10.1001/archpsyc.1978.01770280087009 · DOI
Singh, 1976, Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance, Diseases of the Nervous System, 37, 191
Sackett, 1976, Compliance with Therapeutic Regimens
10.1001/archpsyc.1977.01770130045004 · DOI
10.1192/bjp.110.464.46 · DOI
10.1037/h0046007 · DOI
10.1007/BF02289743 · DOI · Paper page
10.1176/ajp.127.12.1631 · DOI
10.1007/BF02289652 · DOI
10.1017/S0033291700006632 · DOI
DiMascio, 1970, Clinical Handbook of Psychopharmacology, 185
10.2307/2948420 · DOI
10.1192/bjp.129.6.513 · DOI
10.1097/00005053-196109000-00003 · DOI
10.1016/S0015-0282(16)35350-X · DOI
10.1001/archpsyc.1981.01780270073010 · DOI
10.1001/archpsyc.1974.01760130049008 · DOI · Paper page
Barofsky, 1976, Compliance with Therapeutic Regimens, 100
10.1037/0022-3514.37.9.1576 · DOI
Nevins, 1977, Adverse response to neuroleptics in schizophrenia, International Journal of Psychoanalytic Psychotherapy, 6, 227
10.1146/annurev.ps.32.020181.002041 · DOI · Paper page
10.1001/archpsyc.1979.01780120013001 · DOI · Paper page
Bock, 1975, Multivariate Statistical Methods in Behavioral Research
10.1111/j.1600-0447.1963.tb07482.x · DOI
10.1136/bmj.1.5283.972 · DOI
10.1001/archpsyc.1975.01760230138011 · DOI · Paper page
10.1001/archpsyc.1978.01770290127012 · DOI
10.1037/0022-006X.46.4.648 · DOI · Paper page
Reilly, 1967, Clinical characteristics and medication history of schizophrenics readmitted to the hospital, International Journal of Neuropsychiatry, 3, 85
Nunnally, 1967, Psychometric Theory
10.1016/0010-440X(77)90047-5 · DOI

Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia: A Comprehensive Review of Recent Literature
Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1007 · Cited by 1,383
Treatment non‐adherence in affective disorders
Lingam, R., & Scott, J. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.1r084.x · Cited by 635
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
Velligan, D. I., Sajatovic, M., Hatch, A., Kramata, P., & Docherty, J. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s124658 · Cited by 333
Cognitive behaviour therapy for schizophrenia
Jones, C., Cormac, I., Silveira da Mota Neto, J. I., & Campbell, C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000524.pub2 · Cited by 269
Retracted
Cross-sectional and Longitudinal Relationships Between Insight and Attitudes Toward Medication and Clinical Outcomes in Chronic Schizophrenia
Mohamed, S., Rosenheck, R., McEvoy, J., Swartz, M., Stroup, S., & Lieberman, J. A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn067 · Cited by 258
A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders
Sendt, K.-V., Tracy, D. K., & Bhattacharyya, S. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.002 · Cited by 245
Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study
McIntyre, A., Gendron, A., & McIntyre, A. (2007) · Depression and Anxiety · doi:10.1002/da.20275 · Cited by 145
Factors Associated with Medication Adherence among Patients with Schizophrenia in Mekelle, Northern Ethiopia
Eticha, T., Teklu, A., Ali, D., Solomon, G., & Alemayehu, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120560 · Cited by 103
“2% [19]; England, 29% [20]; Hong Kong, 30% [15] and Egypt, 74% [21].”
BackgroundResultInfluential
Psychosocial interventions for internalised stigma in people with a schizophrenia-spectrum diagnosis: a systematic narrative synthesis and meta-analysis
Wood, L., Byrne, R., Varese, F., & Morrison, A. P. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.05.001 · Cited by 93
Suicide behaviour over 18 months in recent onset schizophrenic patients: The effects of CBT
Tarrier, N., Haddock, G., Lewis, S., Drake, R., & Gregg, L. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.846 · Cited by 88
Reasons for Quitting Serotonin Reuptake Inhibitor Therapy: Paradoxical Psychological Side Effects and Patient Satisfaction
Bolling, M. Y., & Kohlenberg, R. J. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000080392 · Cited by 74
Triple Stigma of Forensic Psychiatric Patients: Mental Illness, Race, and Criminal History
West, M., Yanos, P., & Mulay, A. (2014) · International Journal of Forensic Mental Health · doi:10.1080/14999013.2014.885471 · Cited by 71
Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia
Konarzewska, B., Wołczyński, S., Szulc, A., Galińska, B., Popławska, R., & Waszkiewicz, N. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.08.015 · Cited by 70
Reviving Research on Medication Attitudes for Improving Pharmacotherapy: Focusing on Adherence
De las Cuevas, C., & de Leon, J. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000450830 · Cited by 47
Are depot antipsychotics more coercive than tablets?: The patient’s perspective
Patel, M., de Zoysa, N., Bernadt, M., Bindman, J., & David, A. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109103133 · Cited by 47
Effectiveness of Switching to Aripiprazole From Atypical Antipsychotics in Patients With Schizophrenia
Kim, S.-W., Shin, I.-S., Kim, J.-M., Lee, J.-H., Lee, Y.-H., Yang, S.-J., & Yoon, J.-S. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31819a68b5 · Cited by 47
Modeling Determinants of Medication Attitudes and Poor Adherence in Early Nonaffective Psychosis: Implications for Intervention
Drake, R. J., Nordentoft, M., Haddock, G., Arango, C., Fleischhacker, W. W., Glenthøj, B., Leboyer, M., Leucht, S., Leweke, M., McGuire, P., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv015 · Cited by 42
Evaluation of motivational interviewing to improve psychotropic medication adherence in adolescents.
Hamrin, V., & Iennaco, J. D. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0187 · Cited by 37
Insight and suicidality in psychosis: A cross-sectional study
Massons, C., Lopez-Morinigo, J.-D., Pousa, E., Ruiz, A., Ochoa, S., Usall, J., Nieto, L., Cobo, J., David, A. S., & Dutta, R. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.059 · Cited by 36
The Role of Five Facets of Mindfulness in a Mindfulness-Based Psychoeducation Intervention for People With Recent-Onset Psychosis on Mental and Psychosocial Health Outcomes
Chien, W. T., Chow, K. M., Chong, Y. Y., Bressington, D., Choi, K. C., & Chan, C. W. H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00177 · Cited by 33
An exploratory, open-label, randomized trial comparing risperidone long-acting injectable with oral antipsychotic medication in the treatment of early psychosis.
Malla, A., Chue, P., Jordan, G., Stip, E., Koczerginski, D., Milliken, H., Joseph, A., Williams, R., Adams, B., Manchanda, R., et al. (2016) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.mach.061213 · Cited by 30
Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China
Mohamed, S., Rosenheck, R., He, H., & Yuping, N. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0824-1 · Cited by 26
Shared decision-making for psychiatric medication: A mixed-methods evaluation of a UK training programme for service users and clinicians
Ramon, S., Morant, N., Stead, U., & Perry, B. (2017) · International Journal of Social Psychiatry · doi:10.1177/0020764017733764 · Cited by 25
Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge
Zhou, Y., Rosenheck, R., Mohamed, S., Ning, Y., & He, H. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.036 · Cited by 23
Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial
Xu, D. (., Gong, W., Caine, E. D., Xiao, S., Hughes, J. P., Ng, M., Simoni, J., He, H., Smith, K. L., Brown, H. S., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010120 · Cited by 21
A comparative study on the safety and efficacy of naltrexone versus baclofen versus acamprosate in the management of alcohol dependence
Kumar, A., Sharma, A., Bansal, P. D., Bahetra, M., Gill, H. K., & Kumar, R. (2020) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_201_19 · Cited by 21
Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication
Widschwendter, C. G., Kemmler, G., Rettenbacher, M. A., Yalcin-Siedentopf, N., & Hofer, A. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1791-y · Cited by 18
Predictors of involuntary patients’ satisfaction with care: prospective study
Bainbridge, E., Hallahan, B., McGuinness, D., Gunning, P., Newell, J., Higgins, A., Murphy, K., & McDonald, C. (2018) · BJPsych Open · doi:10.1192/bjo.2018.65 · Cited by 14
Efficacy of shared decision making on treatment satisfaction for patients with first-admission schizophrenia: study protocol for a randomised controlled trial
Ishii, M., Okumura, Y., Sugiyama, N., Hasegawa, H., Noda, T., Hirayasu, Y., & Ito, H. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-111 · Cited by 13
“The Japanese version of the Drug Attitude Inventory-10 (DAI-10) [25,26] is used to measure attitudes toward medication.”
The relationship between insight and subjective experience in schizophrenia
Kako, Y., Ito, K., Hashimoto, N., Toyoshima, K., Shimizu, Y., Mitsui, N., Fujii, Y., Tanaka, T., & Kusumi, I. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s66121 · Cited by 13
Identifying the Underlying Factors Associated With Patients’ Attitudes Toward Antidepressants: Qualitative and Quantitative Analysis of Patient Drug Reviews
Zolnoori, M., Fung, K. W., Fontelo, P., Kharrazi, H., Faiola, A., Wu, Y. S. S., Stoffel, V., & Patrick, T. (2018) · JMIR Mental Health · doi:10.2196/10726 · Cited by 11
Advanced practice nurses led clinic in a psychiatric hospital: An outcome evaluation in Singapore
Xu, C., Xie, H., Zhou, Z., Govindasamy, A., Mao, R., & Chan, Y. H. (2020) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2020.03.003 · Cited by 10
Patients’ perception of coercion with respect to antipsychotic treatment of psychotic disorders and its predictors
Hirsch, S., Thilo, N., Steinert, T., & Flammer, E. (2021) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-021-02083-z · Cited by 9
Non-Adherence to Antiseizure Medications: Rate and Predictors in Saudi Arabia
Alrukban, N. A., Alotaibi, S. A., Alanizy, L. N., Saleh, A., & Alsfouk, B. A. (2024) · Medicina · doi:10.3390/medicina60101649 · Cited by 7
Seclusion, Restraint, Therapeutic Alliance, and Legal Admission Status: What Really Matters?
O’Callaghan, A. K., Plunkett, R., & Kelly, B. D. (2022) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000665 · Cited by 5
Antipsychotic Adherence Intervention for Veterans over 40 with Schizophrenia: Results of a Pilot Study
Mittal, D., Owen, R., Lacro, J., Landes, R., Edlund, M., Valenstein, M., & Jeste, D. (2009) · European Psychiatry · doi:10.1016/s0924-9338(09)71404-x · Cited by 4
Intentional non-adherence to antipsychotic medication in patients with schizophrenia
Yaegashi, H., Haga, M., Misawa, F., Mizuno, Y., Suzuki, T., & Takeuchi, H. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.10.018 · Cited by 1
Antipsychotic medication non-adherence and its associated factors among patients with schizophrenia in Ethiopia: A cross-sectional study.
Huang, Y., Adigawe, T., Tang, S., & Sun, M. (2025) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2025.151939 · Cited by 1

Authors: Hogan, T. P., Awad, A. G., & Eastwood, R.
Venue: Psychological Medicine
Publisher: Cambridge University Press (CUP)
Published: 1983-02
Volume: 13
Issue: 1
Pages: 177-183
ISSN: 0033-2917 (ISSN-L)
1469-8978
DOI: 10.1017/s0033291700050182
OpenAlex: W2116246373
Cited by: 1,028
References: 0
FWCI: 3.15
Type: journal article
Language: en
Open access: closed
Licence: www.cambridge.org/core/terms (unspecified, 9655 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources